{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001468748","name":"Kodiak Sciences Inc.","summary":"Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company developing retinal medicines using its proprietary Antibody Biopolymer Conjugate (ABC) platform. Its lead product, Zenkuda (tarcocimab tedromer/KSI-301), is an anti-VEGF therapy with a 20-day ocular half-life that has completed four Phase 3 studies in diabetic retinopathy, retinal vein occlusion, and wet AMD. Kodiak also develops KSI-501 (anti-IL-6/VEGF bispecific) and KSI-101 (IL-6/VEGF bispecific for macular inflammation), and operates its own commercial-scale manufacturing facility called Ursus.","people":[],"products":[{"name":"Zenkuda (tarcocimab tedromer / KSI-301)","type":"platform","description":"Anti-VEGF intravitreal biologic therapy built on the ABC platform for diabetic retinopathy, retinal vein occlusion, and wet AMD with a 20-day mean ocular half-life."},{"name":"KSI-501","type":"platform","description":"Anti-IL-6/VEGF-trap bispecific therapy built on the ABC platform for retinal vascular diseases including wet AMD, currently in Phase 3 DAYBREAK study."},{"name":"KSI-101","type":"platform","description":"High-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF for macular edema secondary to inflammation (MESI), in Phase 3 PEAK and PINNACLE studies."},{"name":"Antibody Biopolymer Conjugate Drug (ABCD) Platform","type":"platform","description":"Platform extension embedding small molecules and APIs into Kodiak's biopolymer backbone for high drug-antibody ratio medicines targeting ophthalmic and systemic diseases."},{"name":"Ursus Manufacturing Facility","type":"hardware","description":"Dedicated commercial-scale drug substance manufacturing facility custom-designed and built in collaboration with Lonza, commissioned and regulatory approved."}],"partnerships":[{"partner_name":"Lonza","partnership_type":"development","description":"Collaborated with Lonza to custom-design and build Ursus, Kodiak's dedicated commercial-scale drug substance manufacturing facility.","start_date":null}],"affiliations":[],"origin":{"leaf":"926c29f60775450504d6555b1801b82f58ba2dd404fdbac8672a523ac5fa9a67","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"e3e0c6331a0a774ee04ef215e1b9105af8146f08800695af7df062bdb49e04f4","parent":"9ca8e0de67b9609e811fc05b94f430d9541c24e8007d7b7ba6c52b86342367c7","source":"0001193125-26-134887","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":336,"hourly_limit":500,"remaining":164,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}